Search Results - "Temurhan, S"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Association Between HLA Antibodies and Different Sensitization Events in Renal Transplant Candidates by Akgul, S.U, Ciftci, H.S, Temurhan, S, Caliskan, Y, Bayraktar, A, Tefik, T, Kaya, I.A, Canitez, I.O, Demir, E, Yazici, H, Bakkaloglu, H, Aydin, A.E, Turkmen, A, Nane, I, Aydin, F, Oguz, F.S

    Published in Transplantation proceedings (01-04-2017)
    “…Abstract Background Human leukocyte antigen (HLA) allo-immunization is caused by various events such as blood transfusions, pregnancies, or organ…”
    Get full text
    Journal Article
  2. 2

    Panel Reactive Antibody Responses Against Influenza Vaccination in Kidney Transplant Recipients by Khishigsuren, B., Demir, E., Akgul, S.U., Temurhan, S., Ucar, A.R., Dirim, A.B., Catikkas, N.M., Bayraktar, A., Caliskan, Y., Yazici, H., Oguz, F.S., Turkmen, A., Sever, M.S.

    Published in Transplantation proceedings (01-05-2019)
    “…Seasonal influenza is an important cause of morbidity and mortality in the post-transplant period; therefore, the influenza vaccination has been recommended…”
    Get full text
    Journal Article
  3. 3

    Effects of Rituximab on Atherosclerotic Biomarkers in Kidney Transplant Recipients by Aliyeva, N., Demir, E., Akgul, S.U., Temurhan, S., Ucar, A.R., Dirim, A.B., Bayraktar, A., Catikkas, N.M., Erol, A., Caliskan, Y., Yazici, H., Yelken, B., Savran, F.O., Turkmen, A.

    Published in Transplantation proceedings (01-05-2019)
    “…Cardiovascular disease is the leading cause of mortality in kidney transplant recipients. Rituximab is widely used in kidney transplantation for a variety of…”
    Get full text
    Journal Article
  4. 4

    Tac-MMF Versus CsA-MMF/CsA-AZA–Based Regimens in Development of De Novo Complement-Binding Anti-HLA Antibodies After Kidney Transplantation by Sahutoglu, T, Akgul, S.U, Caliskan, Y, Yazici, H, Demir, E, Kara, E, Temurhan, S, Savran, F.O, Turkmen, A

    Published in Transplantation proceedings (01-04-2017)
    “…Abstract Background Immunosuppressive regimens with tacrolimus or cyclosporine A (CsA) were compared for graft-related outcomes in conjunction with…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy by Temurhan, S, Akgul, S.U, Caliskan, Y, Artan, A.S, Kekik, C, Yazici, H, Demir, E, Caliskan, B, Turkmen, A, Oguz, F.S, Sever, M.S

    Published in Transplantation proceedings (01-04-2017)
    “…Abstract Background The serum levels of galactose-deficient immunoglobulin (Ig)A1 (Gd-IgA1) represent the most promising candidate biomarker for IgA…”
    Get full text
    Journal Article
  7. 7
  8. 8